SARA Pharm Solutions is proud to announce the publishing of a new paper in ScienceDirect Journal “Results in Physics”. The paper entitled “The influence of UV light on the azathioprine photodegradation: New evidences by photoluminescence” highlights the results about photodegradation process of azathioprine at 300nm wavelength and also UV-VIS and IR absorption spectroscopy evidences of the degradation products. The experimental results are accompanied by DFT calculations. This work was done in collaboration with National Institute of Materials Physics (Romania) on behalf of the Ministry of European Founds as Managing Authority for Operational Program Competitiveness (POC).

SARA Pharm scientists, in collaboration with ‘‘Ilie Murgulescu’’ Institute of Physical Chemistry, Romanian Academy, and Faculty of Applied Chemistry and Material Science, University ‘‘Politehnica’’ of Bucharest, synthesized and characterized shape-stabilized phase change materials (PCMs) based on NaCl–CaCl2 molten salt mixture and mesoporous silica. This is the first study to date to investigate potential advantages of ordered mesoporous silica in composite PCMs. These materials show promise for high-temperature heat storage through combined latent and sensible storage mechanisms. Find out more at

We are proud to announce that our latest manuscript was accepted by Journal of Molecular Structure. The paper reveals the crystal structure of a new anhydrous solid-state form of Azathioprine, determined directly form powder X-Ray diffraction data, employing the direct-space genetic algorithm technique for structure solution, followed by Rietveld refinement, and you can read it here:

Sara Pharm team congratulates our colleague Dumitru Samohvalov for his first paper published in Nature Chemistry : Formation of the layered conductive magnet CrCl2(pyrazine)2through redox-active coordination chemistry.

SARA Pharm Solutions will exhibit at Pharma ChemOutsourcing event on September 17-19, 2018 in Long Branch, NJ, USA.
Please feel free to stop by our stand or contact us in order to arrange a meeting.

Since January 2018 we have been working with our partner NIMP- National Institute of Materials Physics in the AMD-FARMA-MED-RO project (Physico-chemical analyzes, nanostructured materials and devices for pharmaceutical and medical applications in Romania). SARA Pharm has been awarded a grant for this project as a result of the POC competition – section G 1.2.3. -Partnership for knowledge transfer.

We are proud to announce that SARA Pharm has been awarded an Horizon 2020 grant (H2020-MSCA-RISE-2017 for the CLATHROPROBES project whose primary objective is to the design and development of novel, highly efficient chiroptical, luminescent probes for sensing and structural studies of biomolecules based on cage metal complexes as molecular reporters.

Our partners in the project are UNIVERSITAT WIEN (Austria), FRIEDRICH-ALEXANDER-UNIVERSITAET ERLANGEN NUERNBERG (Germany), UNIWERSYTET WROCLAWSKI (Poland) and SC Princeton Biomolecular Research Labs (Ukraine).

SARA Pharm Solutions will participate in CPhI Worldwide in Frankfurt, Germany, 24th-26th October, 2017.

Please contact us in order to arrange a meeting.

SARA Pharm Solutions will exhibit at Pharma ChemOutsourcing event on September 18-20, 2017 in Long Branch, NJ, USA.
Please feel free to stop by our stand or contact us in order to arrange a meeting.

We are proud that the Nifuroxazide polymorph screening case-study performed in-house by SARA Pharm was recently published in CrystEngComm:!divAbstract.

We use cookies to give you the best online experience. By agreeing you accept the use of cookies in accordance with our cookie policy.

Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

In order to use this website we use the following technically required cookies
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

Decline all Services
Accept all Services